99% Savings - Buy Just @1 Rs X
Erbitux 500 Infusion is a prescription drug, available for use as Injection. Colorectal Cancer are some of its major therapeutic uses. Secondary and off-label uses of Erbitux 500 Infusion have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Erbitux 500 Infusion. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Erbitux 500 Infusion include Nausea or vomiting, Headache, Skin Rash. Apart from the aforementioned side effects, Erbitux 500 Infusion can also lead to other problems, which have been listed below. These side effects of Erbitux 500 Infusion are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Erbitux 500 Infusion's effect is Severe during pregnancy and Severe for lactating mothers. Warnings related to Erbitux 500 Infusion's effects on the liver, heart and kidney, if any, have been listed below.
Erbitux 500 Infusion is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Disease, Calcium Deficiency, Potassium Deficiency are examples of such conditions. Other contraindications of Erbitux 500 Infusion have been discussed in the sections ahead.
Drug reaction of Erbitux 500 Infusion with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Erbitux 500 Infusion is considered not safe while driving, and is not addictive.
Erbitux 500 Infusion is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Erbitux 500 Infusion safe for pregnant women?
Pregnant women may get severe side effects after taking Erbitux. If you are pregnant, do not take Erbitux without a doctor's advice.
Is the use of Erbitux 500 Infusion safe during breastfeeding?
Erbitux should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Erbitux 500 Infusion on the Kidneys?
Using Erbitux does not have any harmful effects on kidneys.
What is the effect of Erbitux 500 Infusion on the Liver?
Erbitux is not harmful for the liver.
What is the effect of Erbitux 500 Infusion on the Heart?
There may be an adverse effect on the heart after taking Erbitux. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
If you are suffering from any of the following diseases, you should not take Erbitux 500 Infusion unless your doctor advises you to do so -
Is this Erbitux 500 Infusion habit forming or addictive?
Forming a habit of Erbitux 500 Infusion has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Erbitux 500 Infusion. So it is best to avoid driving.
Is it safe?
Yes, but consume Erbitux 500 Infusion only on doctor's advice.
Is it able to treat mental disorders?
Erbitux 500 Infusion is unable to treat or cure mental disorders.
Interaction between Food and Erbitux 500 Infusion
Taking Erbitux 500 Infusion with food is safe.
Interaction between Alcohol and Erbitux 500 Infusion
No research has been done on this till date. Therefore, it is not known what the effect of taking Erbitux 500 Infusion with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Erbitux® (cetuximab)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 870
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 317-319